If your constipation lasts for more than three days, speak with your doctor about options to help. You might need to add a ...
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
New Scientist on MSN2d
GLP-1 drugs like Ozempic and Wegovy lower the risk of 42 conditionsThe benefits of taking GLP-1 agonists seem to outweigh the risks, at least when taken for approved uses, according to an ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the ...
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
Novo Nordisk ( NYSE:NVO) and Eli Lilly ( NYSE:LLY) are making headlines againthis time, for potential benefits beyond weight ...
Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...
Hosted on MSN2d
GLP-1 Drugs Cut Risk of Alzheimer's, NVO & LLY Shares RiseThe stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...
HealthDay on MSN2d
Popular GLP-1 Drugs Are Shaping Health Beyond Weight Loss & DiabetesPopular GLP-1 medications for weight loss and diabetes may have unexpected benefits for reducing risks for conditions ...
Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback